| 18-817 |
Hikma Pharmaceuticals USA Inc., et al. v. Vanda Pharmaceuticals Inc. |
Federal Circuit |
2018-12-27 |
Denied |
CVSGAmici (3)Relisted (2) |
generic-drugs inventive-concept medical-patent medical-treatment method-of-treatment natural-law patent-eligibility routine-and-conventional section-101 |
Whether patents that claim a method of medically treating a patient automatically satisfy Section 101 of the Patent Act, even if they apply a natural … |